| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.3 |